Gilead Sciences to Release Second Quarter 2013 Financial Results on Thursday, July 25, 2013

  Gilead Sciences to Release Second Quarter 2013 Financial Results on
  Thursday, July 25, 2013

                    Conference Call and Webcast to Follow

Business Wire

FOSTER CITY, Calif. -- July 18, 2013

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter
2013 financial results will be released on Thursday, July 25, at 4:05 p.m.
Eastern Time. At 4:30 p.m. Eastern Time, Gilead’s management will host a
conference call to discuss the company’s financial results for the second
quarter and provide a general business update. The conference call will be
accessible via the internet from the company’s website.

To access the webcast link, log on to Please connect to the
company’s website at least 15 minutes prior to the conference call to ensure
adequate time for any software download that may be required to listen to the
webcast. Alternatively, please call 1-866-730-5771 (U.S.) or 1-857-350-1595
(international) and dial the participant passcode 26371472 to access the call.
Telephone replay will be available approximately two hours after the call
through 11:59 p.m. Eastern Time, July 28, 2013. To access the replay, please
call 1-888-286-8010 (U.S.) or 1-617-801-6888 (international) and dial the
participant passcode 87549354. The webcast will be archived on
for one year.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and
commercializes innovative therapeutics in areas of unmet medical need. The
company’s mission is to advance the care of patients suffering from
life-threatening diseases worldwide. Headquartered in Foster City, California,
Gilead has operations in North America, Europe and Asia Pacific.

 For more information on Gilead Sciences, please visit or call
   the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).


Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor Relations
Press spacebar to pause and continue. Press esc to stop.